Remarkably, phosphorylated tau (p-tau) forms in MTBR, such as p-tau181, p-tau217, and p-tau231, are elevated in the CSF and blood of AD patients, underscoring their utility as biomarkers for diagnosis and intervention assessment. The gene discussed is MAPT; the disease is Alzheimer disease.